Visualize What You Can Do with Imaging Mass Cytometry: Uncovering Spatial Biology

Thank you to our speakers and attendees at the October 2021 IMC Summit: Uncovering Spatial Biology. Throughout the meeting we saw how Imaging Mass Cytometry™ (IMC™) was used to markedly transform the investigation of the tissue microenvironment and decipher the complex secrets of spatial biology.

We hope you were inspired by the expert users and leaders in the Imaging Mass Cytometry community who shared their current research, tips and insights gained using IMC.

To tap into the wealth of information from this meeting, just go to the agenda for links. Learn from the experience of other IMC users about how to apply this powerful technology to your work and discover data analysis solutions that can enhance your results.
See agenda and presentations

An Exciting Agenda

The 2021 IMC Summit agenda includes translational research presentations, a roundtable discussion from hands-on expert users, a panel discussion on getting started and several talks focused on data analysis. Peruse through the agenda below and click on links to see the sessions.

Or download the agenda to share with your colleagues.

If you have any questions, want to request a seminar or an FAS visit at your institution, or want a quote, please let us know.
Get more info

October was Breast Cancer Awareness Month

In honor of this month, three excellent presentations on this topic were included in the Making an impact in breast cancer research session that kicked off the day. Our speakers selected the charity Touch, The Black Breast Cancer Alliance™, which will receive a $3,000 donation from Fluidigm to support the great research aimed at combating this disease.

Learn more about this organization at touchbbca.org or on Twitter, @touchbbca.

Topics and Speakers
Welcome to the IMC Summit 2021	View on demand
» Welcome address Chris Linthwaite President and CEO, Fluidigm Michelle Macpherson (Moderator) Director of Product Management, Imaging Mass Cytometry, Fluidigm
Making an impact in breast cancer research	View on demand
» Introduction Bernd Bodenmiller, PhD Dual Professor for Quantitative Medicine University of Zurich and Institute for Molecular Health Sciences, ETH Zurich » Capturing diversity in tumor microenvironments: Biological determinants of breast cancer disparities Melissa Davis, PhD Assistant Professor of Cell and Developmental Biology Scientific Director of the International Center for the Study of Breast Cancer Subtypes, Weill Cornell Medicine » Obesity, inflammation and cancer Daniela Quail, PhD Assistant Professor, Department of Physiology Rosalind and Morris Goodman Cancer Research Centre, McGill University
IMC Summit Keynote Presentation	View on demand
» Using IMC to understand the neuroinflammation of severe COVID-19 infection Bertram Bengsch, MD, PhD Group Leader, Department of Internal Medicine II University Medical Center Freiburg
Break Visit The Promise of IMC and Product Kiosks
Ask an FAS	View on demand
» Sample preparation and panel design Leigh-Anne McDuffus Field Applications Specialist, Proteomics, Fluidigm
Expert User Insights: Roundtable Discussion	View on demand
» Roundtable discussion Noah Saederup, PhD (Moderator) Senior Product Manager, Mass Cytometry Reagents, Fluidigm Dan Traum (Panelist) Research Specialist, University of Pennsylvania Marieke E. Ijsselsteijn (Panelist) PhD Candidate, Leiden University Medical Center Anthony Colombo (Panelist) PhD Student in Biostatistics at University of Southern California, in collaboration with Cedars-Sinai Graduate School of Biomedical Sciences
Ask an FAS	View on demand
» ROI selection and considerations in selecting a data analysis pipeline Eric Swanson, PhD Senior Field Applications Specialist, Proteomics, Fluidigm
Introducing Maxpar® OnDemand Antibodies	View on demand
» Introducing Maxpar® OnDemand Antibodies Clinton Hupple Product Manager, Proteomics, Fluidigm
2021 Publication Spotlights	View on demand
» The spatial landscape of lung pathology during COVID-19 progression André Rendeiro, PhD Postdoctoral Associate in Computational Biomedicine Institute for Computational Biomedicine and Englander Institute for Precision Medicine, Weill Cornell Medicine » Immunogenomics of colorectal cancer response to checkpoint blockade: Analysis of the KEYNOTE 177 trial and validation cohorts Michele Bortolomeazzi (Joint Speaker) PhD Student, Cancer Research UK King’s Health Partners Centre Cancer Systems Biology Group, King’s College London, Francis Crick Institute Lucia Montorsi, PhD (Joint Speaker) Assistant Professor, Department of Physiology Rosalind and Morris Goodman Cancer Research Centre, McGill University
Ask an FAS	View on demand
» Getting the most out of your data analysis Wendell Smith, PhD Field Applications Specialist II, Proteomics, Fluidigm
Getting Started: Panel Discussion	View on demand
» Panel discussion Michelle Macpherson (Moderator) Director of Product Management, Imaging Mass Cytometry, Fluidigm Hiran Ravichandran, MS (Panelist) Research Associate, Weill Cornell Medicine Aida Meghraoui-Kheddar, PhD, PharmD (Panelist) Senior Postdoc, Institute of Molecular and Cellular Pharmacology Corinne Ramos, MBA, PhD (Panelist) Innovation & Marketing Director, ImaBiotech
Ask an FAS	View on demand
» Dual-mode system use, calibration and other instrument operation Ron Cohn, MS Senior Field Applications Specialist, Proteomics, Fluidigm
Break
Data Analysis Session I: The importance of cell segmentation in the data analysis pipeline	View on demand
» Notes from the bench: IMC data analysis from a biologist’s perspective Hartland Jackson, PhD Investigator, Lunenfeld-Tanenbaum Research Institute » Imaging Mass Cytometry and single-cell segmentation of lung tissue samples Jay Hirota, PhD (Joint Speaker) Canada Research Chair in Respiratory Mucosal Immunology Assistant Professor of Medicine, McMaster University Kjetil Ask, PhD (Joint Speaker) Associate Professor, Firestone Institute for Respiratory Health McMaster University
Data Analysis Session II: Visiopharm® high-multiplex software and a new import function	View on demand
» Build a strong foundation: Powerful cell segmentation with Visiopharm’s advanced phenotyping software Brit Boehmer, PhD Technical Sales Specialist, Visiopharm
Data Analysis Session III: An operationalized pipeline with IF data merging, HALO® and ImaCytE	View on demand
» Integrating IMC into an initial QC and deep multi-omic phenotyping workflow: A tissue-sparing approach to maximize the amount of remaining clinically collected tissues for other spatial technologies M. Caleb Marlin, PhD Project Manager, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation
Data Analysis Session IV: Data analysis methods in emerging applications	View on demand
» Barcoded IMC assays for an efficient spatial profiling of 3D spheroids Vito Zanotelli, PhD Recently from the Bodenmiller Lab, Department of Quantitative Biomedicine, University of Zurich

For Research Use Only. Not for use in diagnostic procedures.

Limited Use Label License: The purchase of this Fluidigm Instrument and/or Consumable product conveys to the purchaser the limited, nontransferable right to use with only Fluidigm Consumables and/or Instruments respectively except as approved in writing by Fluidigm: www.fluidigm.com/legal/salesterms. Patents: fluidigm.com/legal/notices. Trademarks: Fluidigm, the Fluidigm logo, Imaging Mass Cytometry, IMC and Maxpar are trademarks and/or registered trademarks of Fluidigm Corporation or its affiliates in the United States and/or other countries. All other trademarks are the sole property of their respective owners. ©2021 Fluidigm Corporation. 11/2021

Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.

Visualize What You Can Do with Imaging Mass Cytometry: Uncovering Spatial Biology

An Exciting Agenda

Break

Break